Healthcare-associated infections (HAIs) are a major public health problem. The aim of the study was to describe the evolution of the level of resistance of germs to antibiotics. Methods: Prospective and analytical study that took place from January to April 2021 on 67 newborns suspected of bacterial infection and with a positive blood culture. Results: The mean gestational age was 35.7 weeks, 69% of patients were born vaginally, and 48% were in a level 3 maternity hospital. Prematurity (34%) and intrapartum asphyxia (24%) were the most common reasons for admission. The main germs found were Staphylococcus aureus (40.2%), Staphylococcus Coagulase Negative (28.3%), Klebsiella pneumoniae (30%), Aeromonas salmonicida (1.5%); 60% of Staphylococcus Coagulase Negative (SCNs) and 45% of S. aureus were resistant to penicillin; 75% of K. pneumoniae produced Extended-spectrum β-lactamase (ESBL). Multi Antibiotic Resistant Bacteria were found in newborns who received care to help them adapt to extrauterine life (p = 0.0000) and significantly increased the risk of death (p < 0.001). The mean length of hospital stay was 13.2 days, and the mortality rate was 19.4%. Conclusion: Good hand hygiene and optimal disinfection practices are necessary to limit HAI-related morbidity and mortality.
References
[1]
Reinhart, K., Daniels, R., Kissoon, N., Machado, F.R., Schachter, R.D. and Finfer, S. (2017) Recognizing Sepsis as a Global Health Priority—A WHO Resolution. NewEnglandJournalofMedicine, 377, 414-417. https://doi.org/10.1056/nejmp1707170
[2]
Molloy, E.J., Wynn, J.L., Bliss, J., Koenig, J.M., Keij, F.M., McGovern, M., et al. (2020) Neonatal Sepsis: Need for Consensus Definition, Collaboration and Core Outcomes. PediatricResearch, 88, 2-4. https://doi.org/10.1038/s41390-020-0850-5
[3]
Shane, A.L., Sánchez, P.J. and Stoll, B.J. (2017) Neonatal Sepsis. The Lancet, 6736, 1-11.
[4]
Popescu, C.R., Cavanagh, M.M.M., Tembo, B., Chiume, M., Lufesi, N., Goldfarb, D.M., et al. (2020) Neonatal Sepsis in Low-Income Countries: Epidemiology, Diagnosis and Prevention. ExpertReviewofAnti-infectiveTherapy, 18, 443-452. https://doi.org/10.1080/14787210.2020.1732818
[5]
Giannoni, E., Agyeman, P.K.A., Stocker, M., Posfay-Barbe, K.M., Heininger, U., Spycher, B.D., et al. (2018) Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study. TheJournalofPediatrics, 201, 106-114.e4. https://doi.org/10.1016/j.jpeds.2018.05.048
[6]
World Health Organization (WHO) (2020) Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions. World Health Organization (WHO).
[7]
Lavoie, P.M., Popescu, C.R., Molyneux, E.M., Wynn, J.L., Chiume, M., Keitel, K., et al. (2019) Rethinking Management of Neonates at Risk of Sepsis. TheLancet, 394, 279-281. https://doi.org/10.1016/s0140-6736(19)31627-7
[8]
Lasme-Guillao, E., Amon-Tanoh-Dick, F., GBonon, V., Akaffou, E.A., Kabas, R. and Faye-Kette, H. (2011) Infections a Klebsiella pneumonia et Enterobacter cloacae en néonatologie a Abidjan. JournaldePédiatrieetdePuériculture, 24, 118-124. https://doi.org/10.1016/j.jpp.2011.03.002
[9]
Folquet, M.A., et al. (2015) Update of the Profile of Bacterial Infections in Newborns at the Cocody University Hospital in Abidjan. JournaldePédiatrieetde Puericulture, 29, 8-14.
[10]
Cantey, J.B. and Milstone, A.M. (2015) Bloodstream Infections: Epidemiology and Resistance. ClinicsinPerinatology, 42, 1-16. https://doi.org/10.1016/j.clp.2014.10.002
[11]
Zea-Vera, A. and Ochoa, T.J. (2015) Challenges in the Diagnosis and Management of Neonatal Sepsis. JournalofTropicalPediatrics, 61, 1-13. https://doi.org/10.1093/tropej/fmu079
[12]
Bhatta, D.R., Hosuru Subramanya, S., Hamal, D., Shrestha, R., Gauchan, E., Basnet, S., et al. (2021) Bacterial Contamination of Neonatal Intensive Care Units: How Safe Are the Neonates? AntimicrobialResistance&InfectionControl, 10, Article No. 26. https://doi.org/10.1186/s13756-021-00901-2
[13]
Camacho-Gonzalez, A., Spearman, P.W. and Stoll, B.J. (2013) Neonatal Infectious Diseases: Evaluation of Neonatal Sepsis. PediatricClinicsofNorthAmerica, 60, 367-389. https://doi.org/10.1016/j.pcl.2012.12.003
[14]
Murphy, K. and Weiner, J. (2012) Use of Leukocyte Counts in Evaluation of Early-Onset Neonatal Sepsis. PediatricInfectiousDiseaseJournal, 31, 16-19. https://doi.org/10.1097/inf.0b013e31822ffc17
[15]
Ehl, S., Gehring, B. and Pohlandt, F. (1999) A Detailed Analysis of Changes in Serum C-Reactive Protein Levels in Neonates Treated for Bacterial Infection. EuropeanJournalofPediatrics, 158, 238-242. https://doi.org/10.1007/s004310051058
[16]
Ehl, S., Gering, B., Bartmann, P., Högel, J. and Pohlandt, F. (1997) C-Reactive Protein Is a Useful Marker for Guiding Duration of Antibiotic Therapy in Suspected Neonatal Bacterial Infection. Pediatrics, 99, 216-221. https://doi.org/10.1542/peds.99.2.216
[17]
Benitz, W.E., Han, M.Y., Madan, A. and Ramachandra, P. (1998) Serial Serum C-Reactive Protein Levels in the Diagnosis of Neonatal Infection. Pediatrics, 102, e41-e41. https://doi.org/10.1542/peds.102.4.e41
[18]
Bomela, H.N., Ballot, D.E., Cory, B.J. and Cooper, P.A. (2000) Use of C-Reactive Protein to Guide Duration of Empiric Antibiotic Therapy in Suspected Early Neonatal Sepsis. ThePediatricInfectiousDiseaseJournal, 19, 531-535. https://doi.org/10.1097/00006454-200006000-00008
[19]
Chirico, G. and Loda, C. (2011) Laboratory Aid to the Diagnosis and Therapy of Infection in the Neonate. PediatricReports, 3, e1. https://doi.org/10.4081/pr.2011.e1
[20]
Hofer, N., Zacharias, E., Müller, W. and Resch, B. (2012) An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks. Neonatology, 102, 25-36. https://doi.org/10.1159/000336629
[21]
Huber, S., Hetzer, B., Crazzolara, R. and Orth-Höller, D. (2020) The Correct Blood Volume for Paediatric Blood Cultures: A Conundrum? ClinicalMicrobiologyandInfection, 26, 168-173. https://doi.org/10.1016/j.cmi.2019.10.006
[22]
World Health Organization (2013) Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses.
[23]
Zhou, J. and Chen, S. (2022) Knowledge, Attitudes, and Practices of NICU Doctors and Nurses toward Prevention and Control of Nosocomial Infection with Multidrug Resistant Organism. FrontiersinPediatrics, 10, Article ID: 817030. https://doi.org/10.3389/fped.2022.817030
[24]
Choobdar, F., Vahedi, Z., Khosravi, N., Khalesi, N., Javid, A. and Shojaee, S. (2020) Nosocomial Infection in an Iranian Neonatal Intensive Care Unit: Hospital Epidemiology and Risk Factors. ArchivesofPediatricInfectiousDiseases, 8, e96850. https://doi.org/10.5812/pedinfect.96850
[25]
Okomo, U., Akpalu, E.N.K., Le Doare, K., Roca, A., Cousens, S., Jarde, A., et al. (2019) Aetiology of Invasive Bacterial Infection and Antimicrobial Resistance in Neonates in Sub-Saharan Africa: A Systematic Review and Meta-Analysis in Line with the STROBE-NI Reporting Guidelines. TheLancetInfectiousDiseases, 19, 1219-1234. https://doi.org/10.1016/s1473-3099(19)30414-1
[26]
Campeotto, F., Garnier, F., Kalach, N., Soulaines, P., Dupont, C. and Raymond, J. (2004) Nosocomial Acquisition of Multidrug-Resistant Bacteria in a Neonatal Unit: Prospective Study and Analysis of Risk Factors. ArchivesdePédiatrie, 11, 1314-1318. https://doi.org/10.1016/j.arcped.2004.05.020
[27]
Labi, A., Bjerrum, S., Enweronu-Laryea, C.C., Ayibor, P.K., Nielsen, K.L., Marvig, R.L., et al. (2020) High Carriage Rates of Multidrug-Resistant Gram-Negative Bacteria in Neonatal Intensive Care Units from Ghana. OpenForumInfectiousDiseases, 7, ofaa109. https://doi.org/10.1093/ofid/ofaa109
